Synthetic Data in MR Spectroscopy: Current Practices, Applications, and Considerations
Authors:
- John T. LaMasterJLJohn T. LaMaster
- Aaron T. GudmundsonAGAaron T. Gudmundson
- Alireza AbaeiAAAlireza Abaei
- Seyma AlcicekSASeyma Alcicek
- Arturo AlvaradoAAArturo Alvarado
- Ovidiu AndronesiOAOvidiu Andronesi
- Tiffany BellTBTiffany Bell
- Wolfgang BognerWolfgang Bogner
- Hanna BuglerHBHanna Bugler
- Alexander R. CravenACAlexander R. Craven
- Cristina CudalbuCCCristina Cudalbu
- Alma DavidsonADAlma Davidson
Open Access
- 17 November 2026
- journal article
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (12)
Abstract
Synthetic data generation has become an increasingly important component of methodological development in magnetic resonance spectroscopy (MRS), particularly in contexts where ground‐truth in vivo measurements are limited, noisy, or inaccessible. This review provides a structured overview of current practices in synthetic MRS data generation, with emphasis on the physical, biochemical, and computational assumptions that underpin commonly used models. A decomposition of synthetic MRS data is presented in terms of core building blocks, including basis sets, signal formation models, and metabolite parameter distributions such as concentration and relaxation properties. This framework is extended to advanced components required for realistic data synthesis, including baseline and nuisance signals, spatial encoding effects such as coil sensitivities and field inhomogeneities, k‐space sampling and gradient imperfections, as well as sample‐specific and temporal dynamics. Beyond single‐voxel modeling, synthetic data generation across multiple MRS modalities is discussed, including functional MRS, diffusion‐weighted MRS, and spectroscopic imaging, with emphasis on modality‐specific challenges such as physiological variability, motion, and confounding signal contributions. The role of synthetic data in clinical and preclinical research, acquisition optimization, software validation, and emerging artificial intelligence applications is further examined, with particular attention to domain shift and representational realism. Current practices in validation, reporting standards, and data accessibility are also reviewed, and key gaps limiting reproducibility and interoperability across studies are identified. Overall, this work provides a unified conceptual framework for synthetic MRS data generation, clarifies underlying assumptions across modeling choices, and outlines open challenges toward improving realism, standardization, and utility in both methodological and translational applications. Conducted by the MRS Synthetic Data Working Group under the Code & Data Sharing Committee of the MRS Study Group of the International Society for Magnetic Resonance in Medicine (ISMRM), this review encompasses the existing literature, supplemented by the collective experience and in‐house methodologies of its contributors, providing a community perspective that extends beyond the published record.Funding Information
- National Institutes of Health (R01 EB035529)
- National Institutes of Health (R21 EB033516)
- National Institutes of Health (R00 AG02230)
- National Institutes of Health (K99 AG080084)
- National Institutes of Health (K99 EB034768)
- National Institutes of Health (R01 EB016089)
- National Institutes of Health (R01 EB023963)
- National Institutes of Health (R01 EB032788)
- National Institutes of Health (P41 EB031771)
- National Institutes of Health (R01 EB031787)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (225289)
- Japan Society for the Promotion of Science (22H03002)
- Japan Society for the Promotion of Science (23K24263)
- Japan Society for the Promotion of Science (24K02541)
- Japan Society for the Promotion of Science (24K02387)
- Japan Society for the Promotion of Science (24K10740)
- Japan Society for the Promotion of Science (25K21813)
- Japan Society for the Promotion of Science (25K10856)
- Japan Society for the Promotion of Science (25K10823)
- Japan Agency for Medical Research and Development (JP24wm0625302)
- Japan Agency for Medical Research and Development (JP24wm0625307)
- HORIZON EUROPE European Research Council (101088351)
- Austrian Science Fund (P34198)
- Austrian Science Fund (PAT4912324)
- Austrian Science Fund (I6037)
- Austrian Science Fund (P36328)
This publication has 177 references indexed in Scilit:
- In Vivo NMR Spectroscopy2018
- Diffusion-Weighted Magnetic Resonance Spectroscopy2015
- Tissue correction for GABA‐edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxationsJournal of Magnetic Resonance Imaging, 2015
- Combined parallel and partial fourier MR reconstruction for accelerated 8‐channel hyperpolarized carbon‐13 in vivo magnetic resonance Spectroscopic imaging (MRSI)Journal of Magnetic Resonance Imaging, 2013
- Optimized glutamate detection at 3TJournal of Magnetic Resonance Imaging, 2009
- Magnetic resonance spectroscopy (MRS) and its application in Alzheimer's diseaseConcepts in Magnetic Resonance Part A, 2007
- Proton NMR chemical shifts and coupling constants for brain metabolitesNMR in Biomedicine, 2000
- NMR relaxation times in the human brain at 3.0 teslaJournal of Magnetic Resonance Imaging, 1999
- Quantifying 1 H decoupled in vivo 31 P brain spectraNMR in Biomedicine, 1999
- Density Matrices in NMR Spectroscopy: Part IConcepts in Magnetic Resonance, 1990